Previous close | 91.18 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 934 |
Market cap | 45.105M |
Beta (5Y monthly) | 0.95 |
PE ratio (TTM) | 0.05 |
EPS (TTM) | 19.03 |
Earnings date | 30 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Today we're going to take a look at the well-established The Cooper Companies, Inc. ( NASDAQ:COO ). The company's stock...
Key Insights Cooper Companies will host its Annual General Meeting on 19th of March Salary of US$1.05m is part of CEO...
SAN RAMON, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2024. Revenue increased 9% year-over-year to $931.6 million. CooperVision (CVI) revenue up 7% to $621.5 million, and CooperSurgical (CSI) revenue up 12% to $310.1 million.GAAP diluted earnings per share (EPS) of $0.41, down $0.02 or 5% from last year's first quarter.Non-GAAP diluted EPS of $0.